MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Xiao, Junjie ^a,b,c   Jing, Zhi Cheng ^c   Ellinor, Patrick T ^d   Liang, Dandan ^a,b,c   Zhang, Hong ^a,b,c   Liu, Ying ^a,b,c   Chen, Xiaoli ^a,b   Pan, Lei ^a,b   Lyon, Robert ^e   Liu, Yi ^a,b,c   Peng, Lu Ying ^a,b,c   Liang, Xingqun ^a,b   Sun, Yunfu ^a,b   Popescu, Laurentiu M ^f   Condorelli, Gianluigi ^e   Chen, Yi Han ^a,b,c  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c TONGJI UNIVERSITY   (China)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 134; UNCLASSIFIED DRUG; MIRN134 MICRORNA, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DYSPNEA; FEMALE; GENE EXPRESSION PROFILING; HUMAN; LUNG EMBOLISM; MALE; MICROARRAY ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; THORAX PAIN; VALIDATION STUDY; ACUTE DISEASE; BLOOD; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; REPRODUCIBILITY; RISK FACTOR;

ACUTE DISEASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PULMONARY EMBOLISM; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE;

EID: 80053176268     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-159     Document Type: Article

References (34)

1. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med 2010, 363:266-274. 10.1056/NEJMra0907731, 20592294.
2. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med 2003, 163:1711-1717. 10.1001/archinte.163.14.1711, 12885687.
3. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis. Circulation 2003, 108:2726-2729. 10.1161/01.CIR.0000097829.89204.0C, 14656907.
4. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007, 98:756-764.
5. Perrier A, Nendaz MR, Sarasin FP, Howarth N, Bounameaux H. Cost-effectiveness analysis of diagnostic strategies for suspected pulmonary embolism including helical computed tomography. Am J Respir Crit Care Med 2003, 167:39-44. 10.1164/rccm.2106128, 12502474.
6. Schoepf UJ, Goldhaber SZ, Costello P. Spiral computed tomography for acute pulmonary embolism. Circulation 2004, 109:2160-2167. 10.1161/01.CIR.0000128813.04325.08, 15136509.
7. Kearon C. Diagnosis of pulmonary embolism. CMAJ 2003, 168:183-194. 140429, 12538548.
8. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A, Willeit J, Mayr M. Plasma microRNA profiling reveals loss of endothelial mir-126 and other microRNAs in type 2 diabetes. Circ Res 2010, 107:810-817. 10.1161/CIRCRESAHA.110.226357, 20651284.
9. Contu R, Latronico MVG, Condorelli G. Circulating microRNAs as potential biomarkers of coronary artery disease: a promise to be fulfilled?. Circ Res 2010, 105:573-574.
10. Alevizos I, Illei GG. MicroRNAs as biomarkers in rheumatic diseases. Nature Rev Rheumatol 2010, 6:391-398.
11. van Rooij E, Olson EN. Searching for miR-acles in cardiac fibrosis. Cir Res 2009, 104:138-140.
12. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De Simone M, Micheli B, Biglioli P, Achilli F, Martelli F, Maggiolini S, Marenzi G, Pompilio G, Capogrossi MC. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010, 31:2765-2773. 10.1093/eurheartj/ehq167, 2980809, 20534597.
13. Voellenkle C, van Rooij J, Cappuzzello C, Greco S, Arcelli D, Di Vito L, Melillo G, Rigolini R, Costa E, Crea F, Capogrossi MC, Napolitano M, Martelli F. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics 2010, 42:420-426. 10.1152/physiolgenomics.00211.2009, 20484156.
14. Markham DW, Hill JA. MicroRNAs and heart failure diagnosis: MiR-acle or MiR-age?. Circ Res 2010, 106:1011-1013. 10.1161/CIRCRESAHA.110.219030, 20360261.
15. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105:10513-10518. 10.1073/pnas.0804549105, 2492472, 18663219.
16. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009, 106:4402-4407. 10.1073/pnas.0813371106, 2657429, 19246379.
17. Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, Li K, Yu B, Li Z, Wang R, Wang L, Li Q, Wang N, Shan H, Li Z, Yang B. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 2010, 391:73-77. 10.1016/j.bbrc.2009.11.005, 19896465.
18. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T, Müller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010, 107:677-684. 10.1161/CIRCRESAHA.109.215566, 20595655.
19. Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, Goto Y, Nonogi H, Iwai N. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 2010, 56:1183-1185. 10.1373/clinchem.2010.144121, 20395621.
20. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010, 31:659-666.
21. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, Pinto YM. MiR423-5p as a circulating biomarker for heart failure. Circ Res 2010, 106:1035-1039. 10.1161/CIRCRESAHA.110.218297, 20185794.
22. Mishra PK, Tyagi N, Kumar M, Tyagi SC. MicroRNAs as a therapeutic target for cardiovascular diseases. J Cell Mol Med 2009, 13:778-789. 10.1111/j.1582-4934.2009.00744.x, 19320780.
23. Liu J, van Mil A, Vrijsen K, Zhao J, Gao L, Goumans MJ, Doevendans PA, Sluijter JP. MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. J Cell Mol Med 2010,
24. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galiè N, Pruszczyk P, Bengel F, Brady AJ, Ferreira D, Janssens U, Klepetko W, Mayer E, Remy-Jardin M, Bassand JP, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Zamorano JL, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008, 29:2276-2315.
25. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Harris AL. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008, 141:672-675. 10.1111/j.1365-2141.2008.07077.x, 18318758.
26. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 2008, 14:2588-2592. 10.1158/1078-0432.CCR-07-0666, 18451220.
27. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010, 127:118-126.
28. Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW, Lin SC. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 2010, 16:360-364. 10.1111/j.1601-0825.2009.01646.x, 20233326.
29. Yamamoto Y, Kosaka N, Tanaka M, Koizumi F, Kanai Y, Mizutani T, Murakami Y, Kuroda M, Miyajima A, Kato T, Ochiya T. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers 2009, 14:529-538. 10.3109/13547500903150771, 19863192.
30. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol 2010,
31. Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Leeper KV, Popovich J, Quinn DA, Sos TA, Sostman HD, Tapson VF, Wakefield TW, Weg JG, Woodard PK. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006, 354:2317-2327. 10.1056/NEJMoa052367, 16738268.
32. Dimmeler S, Zeiher AM. Circulating microRNAs: novel biomarkers for cardiovascular diseases?. Eur Heart J 2010, 31:2705-2707. 10.1093/eurheartj/ehq221, 20605798.
33. Hoekstra M, van der Lans CA, Halvorsen B, Gullestad L, Kuiper J, Aukrust P, van Berkel TJ, Biessen EA. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun 2010, 394:792-797. 10.1016/j.bbrc.2010.03.075, 20230787.
34. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT, Carter BS, Krichevsky AM, Breakefield XO. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10:1470-1476. 10.1038/ncb1800, 19011622.